Surface M - Search Results

1

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.

Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Surface M, et al. Mov Disord. 2022 Feb;37(2):416-421. doi: 10.1002/mds.28846. Epub 2021 Nov 6. Mov Disord. 2022. PMID: 34741486 Free PMC article.

2

Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease.

Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, Rouleau GA, Hassin-Baer S, Fon EA, Alcalay RN, Gan-Or Z. Yu E, et al. Among authors: surface m. Mov Disord. 2021 Jan;36(1):178-187. doi: 10.1002/mds.28299. Epub 2020 Sep 24. Mov Disord. 2021. PMID: 32970363

3

Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study.

Xu Y, Feeney MP, Surface M, Novak D, Troche MS, Beck JC, Alcalay RN. Xu Y, et al. Among authors: surface m. Mov Disord. 2022 Jun;37(6):1289-1294. doi: 10.1002/mds.28990. Epub 2022 Mar 26. Mov Disord. 2022. PMID: 35338664 Free PMC article.

4

Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease.

Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Surface M, et al. Mov Disord. 2022 Mar;37(3):654. doi: 10.1002/mds.28936. Epub 2022 Jan 29. Mov Disord. 2022. PMID: 35092096 No abstract available.

5

Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?

Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Surface M, et al. Mov Disord. 2022 Aug;37(8):1782. doi: 10.1002/mds.29136. Mov Disord. 2022. PMID: 35980035 No abstract available.

6

Urinary proteome profiling for stratifying patients with familial Parkinson's disease.

Virreira Winter S, Karayel O, Strauss MT, Padmanabhan S, Surface M, Merchant K, Alcalay RN, Mann M. Virreira Winter S, et al. Among authors: surface m. EMBO Mol Med. 2021 Mar 5;13(3):e13257. doi: 10.15252/emmm.202013257. Epub 2021 Jan 22. EMBO Mol Med. 2021. PMID: 33481347 Free PMC article.

7

Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson's Disease?

Alselehdar SK, Chakraborty M, Chowdhury S, Alcalay RN, Surface M, Ledeen R. Alselehdar SK, et al. Among authors: surface m. Int J Mol Sci. 2021 Oct 26;22(21):11522. doi: 10.3390/ijms222111522. Int J Mol Sci. 2021. PMID: 34768952 Free PMC article.

8

Lipidomics Prediction of Parkinson's Disease Severity: A Machine-Learning Analysis.

Avisar H, Guardia-Laguarta C, Area-Gomez E, Surface M, Chan AK, Alcalay RN, Lerner B. Avisar H, et al. Among authors: surface m. J Parkinsons Dis. 2021;11(3):1141-1155. doi: 10.3233/JPD-202476. J Parkinsons Dis. 2021. PMID: 33814463 Free PMC article.

9

COVID-19 manifestations in people with Parkinson's disease: a USA cohort.

Xu Y, Surface M, Chan AK, Halpern J, Vanegas-Arroyave N, Ford B, Feeney MP, Kwei KT, Katus LE, Kuo SH, Shah H, Waters C, Winfield LM, Beck JC, Przedborski S, Fahn S, Alcalay RN. Xu Y, et al. Among authors: surface m. J Neurol. 2022 Mar;269(3):1107-1113. doi: 10.1007/s00415-021-10784-3. Epub 2021 Sep 4. J Neurol. 2022. PMID: 34482434 Free PMC article.

10

Plasma Metabolite Signature Classifies Male LRRK2 Parkinson's Disease Patients.

Dong C, Honrao C, Rodrigues LO, Wolf J, Sheehan KB, Surface M, Alcalay RN, O'Day EM. Dong C, et al. Among authors: surface m. Metabolites. 2022 Feb 5;12(2):149. doi: 10.3390/metabo12020149. Metabolites. 2022. PMID: 35208223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page